Results 311 to 320 of about 88,244 (379)

Synthetic trap‐peptides identify a TOM complex phosphatase – PP2A dephosphorylates Tom6

The FEBS Journal, Volume 293, Issue 1, Page 271-294, January 2026.
Synthetic trap‐peptides facilitate the identification of complete holoenzymes that bind to the target sequence remarkably close to the phosphorylation site. PP4 bound to, but did not dephosphorylate, the peptide substrate taken from yeast Tom6 pSer16, showing that proximity alone does not induce phosphatase activity.
Laura Scheinost, Christina Ludwig, Nico Höfflin, Asli Aras Taskin, Adinarayana Marada, F.‐Nora Vögtle, Chris Meisinger, Maja Köhn   +7 more
wiley   +1 more source

Sc(III) Complexes of Pyclen Derivative Ligands as Probes for Hypoxia: Synthesis, Chemical Characterization, ⁴⁴Sc-Radiolabeling, and Preclinical Assessment. [PDF]

Chemistry
Csupász T, Dahman B, Gál TG, Kapus I, Képes Z, Szücs D, Trencsényi G, Tóth I, Fekete A, Tircsó G.   +9 more
europepmc   +1 more source

Systematic review and meta‐analysis of the efficacy and safety of [177Lu]Lu‐edotreotide ([177Lu]Lu‐DOTATOC) for the treatment of neuroendocrine tumors

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
Abstract [177Lu]Lu‐edotreotide is a radiopharmaceutical therapy (RPT) targeting somatostatin receptors, which are commonly overexpressed on neuroendocrine tumors (NETs). This systematic literature review and meta‐analysis describes the efficacy and safety of [177Lu]Lu‐edotreotide in patients with NETs.
Richard P. Baum, Julia G. Fricke, Tristan Ruhwedel, Holger Amthauer, Erika Patricia Azorin‐Vega, Dieter Hörsch, Riccardo Laudicella, Vikalp Maheshwari, Martin A. Walter, Berna Degirmenci Polack, Simon F. Spiegl, Guillaume P. Nicolas   +11 more
wiley   +1 more source

Establishing Pb-203 production from electrodeposited Tl targets at Brookhaven National Laboratory. [PDF]

EJNMMI Radiopharm Chem
Lin W, Medvedev DG, Cutler CS, Hatcher-Lamarre J.   +3 more
europepmc   +1 more source

Monitoring Response to Combinatorial Immunotherapies by Tracking both T Cells and Natural Killer Cells <i>In Vivo</i> via ImmunoPET-Raman Multimodal Gold Nanostars. [PDF]

ACS Appl Mater Interfaces
Cutshaw GP, Kothadiya S, Uthaman S, Pandya DN, Wen X, Mathew A, Sinha A, Antony I, Vilgelm AE, Wadas TJ, Mitchell JS, Bardhan R.   +11 more
europepmc   +1 more source

Radiolabeling lipoproteins to study and manage disease. [PDF]

Eur J Nucl Med Mol Imaging
Pérez-Medina C, Fisher EA, Fayad ZA, Mulder WJM, Teunissen AJP.   +4 more
europepmc   +1 more source

Rapid and Efficient Radiolabeling of Short Peptides. [PDF]

ACS Omega
Yanvarev DV, Kechko OI, Solyev PN, Tkachev YV, Kochetkov SN, Makarov AA, Mitkevich VA.   +6 more
europepmc   +1 more source

Pharmaceutical development and clinical application of radiolabeled rituximab

, 2009
Thai H. Tran
openalex   +1 more source

Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review. [PDF]

J Clin Med
Giorgio A, Varani M, Lauri C, Bentivoglio V, Nayak P.   +4 more
europepmc   +1 more source

Exploring In Vivo Metal Chelation as an Approach for Pretargeted PET Imaging. [PDF]

ACS Omega
Mishra A, Keeling G, Kim J, T M de Rosales R.   +3 more
europepmc   +1 more source